Futura Medical Share Discussion Threads

[kop202] 16/7/2019 10:27

It's up in 5 -10minutes......but how long does it stay up?Some women can be very demanding

[j777j] 16/7/2019 10:15

The question must be whether any potential licensee decides it is better to conclude a deal at these levels? If not, pay possibly vast amounts more,in a bidding war with other players. The product is first major ED breakthrough in 20 years. Is applied topically Works within 5 to 10 mins v up to one hour for Viagra,Cialis etc. Please form an orderly queue.

[tiananmen] 16/7/2019 09:59

But why wait till Sept/Dec when the writing is on the wall now about the potential

[ragnarr] 16/7/2019 09:52

Assuming regulatory approval for both MED2005 and TPR100 (the odds of which are getting ever more short) this will be in the pounds not pence, however I cant find an explanation for the last few days rise. MED2005 is well off until end of year (earliest end Oct, probably later) and nothing is expected from Thornton & Ross on TPR100 Until Sept earliest. So there is something else out there – Good obviously...but what?

[ch4p_85] 16/7/2019 09:04

135k gone through. Someone is confident!

[j777j] 16/7/2019 08:32

From where I am looking Singer N+1 forecast $90 million in upfront and milestone payments for Europe and USA. That is fairly near to the entire market cap alone. They also forecast 15% royalties. The consensus is the med gel can reach $1 billion in annual sales. Does not take much to work out how many royalties will come in at 25% of that ( $37.5 million pa) up to 100%($150 million pa.) Big big numbers. We also know Eli Lilly bought the remaining 50% its Cialis joint venture from Icos for $2.3 billion. That after having paid $75 million upfront after only a patchy phase 2 trial.

[5oletrader] 16/7/2019 08:22

UP 768%+ since the beginning of this year - keep chasing ;-)

[qs99] 16/7/2019 08:21

Looks like it doesn’t it! DYOR

[ragnarr] 16/7/2019 08:08

something definitely going on ?

[ih_116147] 16/7/2019 07:54

takeover bid imminent = explosionnnn to £1++ quickly

[j777j] 16/7/2019 07:27

There is no doubt that as we get closer to november,awareness will rise.

[qs99] 16/7/2019 06:56

will we see some more fireworks today?

[qs99] 15/7/2019 14:44

well it is being well bought IMO!

[wantage] 15/7/2019 14:25

For all those getting carried away, Lombard odier haven't gone away.every time price moves up on big volume,they reduce.Cant be long before their next rns.

[qs99] 15/7/2019 14:17

double wow

[qs99] 15/7/2019 14:08

wow, there really is some good support here, well done all those that have kept the faith!

[ih_116147] 15/7/2019 12:41

Another MONSTER buying opp guys is the Novartis Spin-off Mereo Biopharma (MPH.L) which trading below cash balance the current market cap is only £44 million thats nothing for a company with 3 x Phase 3 ready Programs . Good news out today on that undiscovered stock , check it out guys you will like it . MPH.L trading at 44p Mereo BioPharma---Focus shifts back to imminent data hxxps://www.trinitydelta.org/research-notes/focus-shifts-back-to-imminent-data/ rNPV valuation of 506p/share We re-introduce our estimates and valuation of Mereo following the completion of the OncoMed transaction. We value Mereo using a rNPV methodology of its four leading assets at £541m ($704m), equivalent to 506p/share or $25.59/ADS (fully diluted). As indicated, there are multiple significant catalysts due in 2019, which could lead to major re-ratings of the shares.

[firstman] 15/7/2019 12:16

It is so clear that this company is very undervalued, if you think that they can wipe out the competition Viagra. By the end of the year is certainly to be expected with a BIG Deal or company Takeover! Definitely!

[firstman] 15/7/2019 12:04

I think some know more and cover up piece by piece.

[ih_116147] 15/7/2019 11:58

Bid could be in the £1-1.20 range

[kop202] 15/7/2019 11:57

You will be rewarded with Brucie Bonus

[j777j] 15/7/2019 11:46

Does Fum manage to remain independent and retain all the rights,or will someone just snap it up? Let's face it there are not that many co's around with a low market cap that might deliver a blockbuster drug ($1 billion sales.) We will find out soon enough.

[ih_116147] 15/7/2019 11:42

RALLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY see you at £1.50++ by year end